RET and glioblastoma: In glioblastoma stem cells, Notch2 further amplifies RET by interacting with complex I subunits, lowering the NAD+/NADH ratio and sustaining proliferation through SIRT1-dependent signaling; pharmacological inhibition of this RET suppresses tumor growth [39].